MODERATE PSORIASIS
Clinical trials for MODERATE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for psoriasis sufferers: Long-Term drug study underway
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug ESK-001 for people with moderate to severe plaque psoriasis. About 1,680 adults who have already been in a prior ESK-001 study will take the drug for 24 weeks, then some may switch to a placebo to see how well…
Matched conditions: MODERATE PSORIASIS
Phase: PHASE3 • Sponsor: Alumis Inc • Aim: Disease control
Last updated May 17, 2026 03:18 UTC
-
New hope for psoriasis patients: Real-World study tests risankizumab
Disease control OngoingThis study tracks how well risankizumab works for adults recently diagnosed with moderate plaque psoriasis (within the last 2 years) who haven't tried advanced treatments before. About 250 people in Greece will receive the drug as prescribed by their doctor and be observed for up…
Matched conditions: MODERATE PSORIASIS
Sponsor: AbbVie • Aim: Disease control
Last updated May 14, 2026 12:04 UTC